SYSTEMIC LUPUS ERTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy offers hope for kids with devastating autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children with severe autoimmune diseases that haven't responded to standard treatments. Researchers are modifying a patient's own natural killer (NK) immune cells to target and remove harmful B cells that drive the disease.…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New lupus treatment shows promise in early human testing
Disease control Recruiting nowThis early-stage clinical trial is testing a new injection called GR1803 in people with systemic lupus erythematosus (lupus). The study aims to see if the treatment is safe and if it helps control lupus symptoms. Researchers will enroll 44 participants who have active lupus despi…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test best shot strategy to protect most vulnerable from COVID and flu
Disease control Recruiting nowThis study aims to find the best way to give COVID-19 booster shots and seasonal flu vaccines to adults with weakened immune systems. Researchers want to know if getting both shots on the same day works as well as getting them a month apart, and if getting COVID boosters every 3 …
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Early trial tests stem cell shot for lupus control
Disease control Recruiting nowThis early-stage study is testing whether adding a single injection of stem cells from umbilical cords to standard lupus treatment is safe and tolerable. It will involve 10 adults with active lupus to see if the therapy can reduce disease activity and improve kidney function. The…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1 • Sponsor: LiveKidney.Bio • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists launch major study to unlock the mystery of fatigue
Knowledge-focused Recruiting nowThis study aims to better understand the different types and causes of fatigue, which is a common symptom in many conditions like cancer, lupus, and chronic fatigue syndrome. Researchers will enroll about 700 adults, both with and without fatigue, to complete questionnaires, phys…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC